Correction to: A de novo compound targeting α-synuclein improves deficits in models of Parkinson's disease is a research paper published in Brain (2023). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R37AG018440
The Michael J. Fox Foundation
Neuropore Therapies Inc.
Neuropore Therapies Inc
National Institute of Aging
Fields of Study
Keywords